# Covis Pharma GmBH – FDA Inspection, Jul 15, 2016

Source: https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/e03436c5-2531-4b26-94ec-738dabe9dd52
Source feed: FDA_Inspections

> FDA inspection 981007 of Covis Pharma GmBH, July 15, 2016. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 314. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 981007
- Company Name: Covis Pharma GmBH
- Inspection Date: 2016-07-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1250807 - 2024-09-19](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/9d7b8cb0-e107-4ecb-bc9d-dba336151f37)
- FDA Inspection 1087302 - 2019-04-05
- FDA Inspection 1071326 - 2018-10-22
- [FDA Inspection 892953 - 2014-07-28](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/88fb2b99-8685-4234-b6dc-1010f35b4c7d)
- FDA Inspection 878312 - 2014-05-21

Company: https://www.keypedia.com/companies/covis-pharma-gmbh/d1616a5d-a379-4021-b5aa-ef8f369c9a92

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c